Additional file 4 of BAFF is a marker of hypogammaglobulinemia, neuroaxonal damage and inflammation in multiple sclerosis patients on ocrelizumab

Supplementary Material 4: Supplementary Fig. 4. Correlations between infection rates over the past 2 years, BAFF and immuno globulin levels. A Correlation between BAFF and total number of infections in prior 2 years. B Correlation between IgG and total number of infections in prior 2 years. C Comparison of total number of infections in the prior 2 years between below median BAFFand above median BAFFgroups. D Comparison of major infections requiring hospitalization in the prior 2 years between below median BAFFand above median BAFFgroups. E Correlation between IgM levels and major infections requiring hospitalization in the prior 2 years. F Correlation between IgM levels and total number of infections in prior 2 years